title: Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure.
authors.affiliation: Department of Cardiology, University of Brescia, Italy. enrico.vizzardi@tin.it
authors.forename: Enrico
authors.initials: E
authors.lastname: Vizzardi
authors.forename: Antonio
authors.initials: A
authors.lastname: D'Aloia
authors.forename: Raffaele
authors.initials: R
authors.lastname: Giubbini
authors.forename: Tania
authors.initials: T
authors.lastname: Bordonali
authors.forename: Silvia
authors.initials: S
authors.lastname: Bugatti
authors.forename: Natalia
authors.initials: N
authors.lastname: Pezzali
authors.forename: Alessia
authors.initials: A
authors.lastname: Romeo
authors.forename: Alessandra
authors.initials: A
authors.lastname: Dei Cas
authors.forename: Marco
authors.initials: M
authors.lastname: Metra
authors.forename: Livio
authors.initials: L
authors.lastname: Dei Cas
mesh_terms: D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood; D015150:Echocardiography, Doppler; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D010101:Oxygen Consumption / Q000502:physiology; D010919:Placebos; D019275:Radiopharmaceuticals; D016037:Single-Blind Method; D013148:Spironolactone / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects*; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D000451:Mineralocorticoid Receptor Antagonists; D010919:Placebos; D019275:Radiopharmaceuticals; D013148:Spironolactone; D017256:Technetium Tc 99m Sestamibi